Lim, P.P.C.; Stempak, L.M.; Malay, S.; Moore, L.N.; Cherian, S.S.S.; Desai, A.P.
Determining the Clinical Utility of 16S rRNA Sequencing in the Management of Culture-Negative Pediatric Infections. Antibiotics 2022, 11, 159.
https://doi.org/10.3390/antibiotics11020159
AMA Style
Lim PPC, Stempak LM, Malay S, Moore LN, Cherian SSS, Desai AP.
Determining the Clinical Utility of 16S rRNA Sequencing in the Management of Culture-Negative Pediatric Infections. Antibiotics. 2022; 11(2):159.
https://doi.org/10.3390/antibiotics11020159
Chicago/Turabian Style
Lim, Peter Paul C., Lisa M. Stempak, Sindhoosha Malay, LeAnne N. Moore, Sree Sarah S. Cherian, and Ankita P. Desai.
2022. "Determining the Clinical Utility of 16S rRNA Sequencing in the Management of Culture-Negative Pediatric Infections" Antibiotics 11, no. 2: 159.
https://doi.org/10.3390/antibiotics11020159
APA Style
Lim, P. P. C., Stempak, L. M., Malay, S., Moore, L. N., Cherian, S. S. S., & Desai, A. P.
(2022). Determining the Clinical Utility of 16S rRNA Sequencing in the Management of Culture-Negative Pediatric Infections. Antibiotics, 11(2), 159.
https://doi.org/10.3390/antibiotics11020159